National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI

Understanding Cancer Series: Blood Stem Cell Transplants
< Back to Main
In English En español
    Posted: 09/01/2006    Reviewed: 09/01/2006
Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
PDF Version  View/Print PDF
PowerPoint Version  View/Print PowerPoint
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

President's Cancer Panel Annual Report: 2006-2007

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Slide 10 : Many Names for the "Self" Antigens previousnext

The scientific name for "self" antigens is major histocompatibility complex (MHC) proteins, and each person bears a unique set. To make matters even more confusing, when these MHC proteins mark the surface of immune cells called leukocytes, the antigens are dubbed human leukocyte antigens (HLAs). Since leukocytes are the cells used for tissue typing, HLAs are what clinicians use to find reasonable matches for their patients. Whether called MHC proteins or HLAs, all are the same thing--"self" antigens. Technicians remove human leukocytes from the blood of potential donors and determine what HLA markers are present.

Many Names for the 'Self' Antigens

< Previous  |  Index  |  Next Slide >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov